G. P. Bodey
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
- Oncology 39
- Neutropenia and Cancer Infections 16
- Cancer Treatment and Pharmacology 15
- Co-authors
- Victor FainsteinRoy L. HopferEmil J. FreireichAndrew W. MaksymiukS. ThongprasertMario A. LunaIoannis ChatzinikolaouGeorge Samonis
- Journals
- The Journal of Infectious Diseases (8 papers)Clinical Infectious Diseases (5 papers)Cancer (4 papers)Investigational New Drugs (1 paper)Annals of Internal Medicine (1 paper)
- Partner nations
- United StatesUnited KingdomGreece
In The Last Decade
G. P. Bodey
69 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Applied Microbiology and Biotechnology 138
- Molecular Medicine 311
- Clinical Biochemistry 284
- Infectious Diseases 652
- Oncology 874
Countries citing papers authored by G. P. Bodey
This map shows the geographic impact of G. P. Bodey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. P. Bodey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. P. Bodey more than expected).
Fields of papers citing papers by G. P. Bodey
This network shows the impact of papers produced by G. P. Bodey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. P. Bodey. The network helps show where G. P. Bodey may publish in the future.
Co-authorship network
The 25 scholars most cited alongside G. P. Bodey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 0 | |
| 2 | 2004 | 126 | |
| 3 | 2002 | 76 | |
| 4 | 2001 | 23 | |
| 5 | 2000 | 185 | |
| 6 | 1998 | 22 | |
| 7 | Hematogenous candidiasis. A review of therapeutic studies of fluconazole and amphotericin B and recommendations for management | 1995 | 3 |
| 8 | 1988 | 6 | |
| 9 | 1988 | 4 | |
| 10 | 1987 | 5 | |
| 11 | Phase I-II clinical trial of thymidine, 5-FU, and PALA given in combination. | 1985 | 2 |
| 12 | Phase II study of spirogermanium in the treatment of metastatic breast cancer. | 1984 | 3 |
| 13 | 1984 | 11 | |
| 14 | 1982 | 5 | |
| 15 | Initial clinical studies of vindesine. | 1981 | 8 |
| 16 | Phase I clinical study of dihydroxyanthracenedione administered on a 5-day iv schedule. | 1981 | 7 |
| 17 | Distribution and inhibition of adenosine deaminase in tissues of man, rat, and mouse. | 1981 | 17 |
| 18 | Phase I clinical evaluation of anguidine. | 1978 | 21 |
| 19 | Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. | 1976 | 114 |
| 20 | Prognostic factors in acute leukemia. | 1976 | 99 |
About G. P. Bodey
G. P. Bodey is a scholar working on Oncology, Molecular Medicine, Endocrinology, Genetics and Hematology, having authored 72 papers that have together received 2.5k indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (16 papers), Cancer Treatment and Pharmacology (15 papers), Cancer therapeutics and mechanisms (8 papers), Glioma Diagnosis and Treatment (7 papers), Brain Metastases and Treatment (6 papers), Antifungal resistance and susceptibility (6 papers), Chemotherapy-related skin toxicity (5 papers) and Acute Myeloid Leukemia Research (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (138 citations), Molecular Medicine (311 citations), Clinical Biochemistry (284 citations), Infectious Diseases (652 citations) and Oncology (874 citations). G. P. Bodey has collaborated with scholars based in United States, United Kingdom and Greece. Frequent co-authors include Victor Fainstein, Roy L. Hopfer, Emil J. Freireich, Andrew W. Maksymiuk, S. Thongprasert, Mario A. Luna, Ioannis Chatzinikolaou, George Samonis, Michael J. Keating and Dima Abi-Said. Their work appears in journals such as The Journal of Infectious Diseases, Clinical Infectious Diseases, Cancer, Investigational New Drugs and Annals of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.